Nordea Investment Management AB Sells 126,984 Shares of CVS Health Corporation $CVS

Nordea Investment Management AB lessened its holdings in CVS Health Corporation (NYSE:CVS) by 2.9% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 4,214,060 shares of the pharmacy operator’s stock after selling 126,984 shares during the period. Nordea Investment Management AB owned 0.33% of CVS Health worth $315,380,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Harbor Capital Advisors Inc. raised its stake in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares during the period. Avion Wealth grew its holdings in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares in the last quarter. Corundum Trust Company INC purchased a new stake in CVS Health during the 3rd quarter valued at approximately $29,000. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health during the second quarter valued at approximately $30,000. Finally, Front Row Advisors LLC lifted its holdings in shares of CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 371 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Trading Up 0.1%

NYSE CVS opened at $80.36 on Tuesday. CVS Health Corporation has a 12 month low of $49.52 and a 12 month high of $85.15. The company’s 50-day moving average price is $78.73 and its 200-day moving average price is $74.02. The stock has a market cap of $102.02 billion, a PE ratio of 211.49, a PEG ratio of 0.74 and a beta of 0.48. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.CVS Health’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Investors of record on Thursday, January 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CVS. Wells Fargo & Company reduced their price target on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a report on Thursday, November 13th. Barclays lifted their target price on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. JPMorgan Chase & Co. increased their price target on CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Mizuho boosted their target price on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $94.86.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.